These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39345453)

  • 41. Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8
    Peng C; Huggins MA; Wanhainen KM; Knutson TP; Lu H; Georgiev H; Mittelsteadt KL; Jarjour NN; Wang H; Hogquist KA; Campbell DJ; Borges da Silva H; Jameson SC
    Immunity; 2022 Jan; 55(1):98-114.e5. PubMed ID: 34932944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts.
    Schenk AD; Gorbacheva V; Rabant M; Fairchild RL; Valujskikh A
    Am J Transplant; 2009 Jan; 9(1):64-73. PubMed ID: 18976292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
    Shi LZ; Goswami S; Fu T; Guan B; Chen J; Xiong L; Zhang J; Ng Tang D; Zhang X; Vence L; Blando J; Allison JP; Collazo R; Gao J; Sharma P
    Cancer Immunol Res; 2019 Nov; 7(11):1803-1812. PubMed ID: 31466995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-1 blockade augments humoral immunity through ICOS-mediated CD4
    Zhang M; Xia L; Yang Y; Liu S; Ji P; Wang S; Chen Y; Liu Z; Zhang Y; Lu S; Wang Y
    Int Immunopharmacol; 2019 Jan; 66():127-138. PubMed ID: 30448635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a T-bet
    Raju S; Xia Y; Daniel B; Yost KE; Bradshaw E; Tonc E; Verbaro DJ; Kometani K; Yokoyama WM; Kurosaki T; Satpathy AT; Egawa T
    J Immunol; 2021 Jun; 206(12):2924-2936. PubMed ID: 34088768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncolytic vaccinia virus induces a novel phenotype of CD8
    Yamashita M; Tasaki M; Murakami R; Arai Y; Nakamura T; Nakao S
    Mol Ther Oncolytics; 2021 Mar; 20():422-432. PubMed ID: 33665362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
    Tsui C; Kretschmer L; Rapelius S; Gabriel SS; Chisanga D; Knöpper K; Utzschneider DT; Nüssing S; Liao Y; Mason T; Torres SV; Wilcox SA; Kanev K; Jarosch S; Leube J; Nutt SL; Zehn D; Parish IA; Kastenmüller W; Shi W; Buchholz VR; Kallies A
    Nature; 2022 Sep; 609(7926):354-360. PubMed ID: 35978192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schrödinger's T Cells: Molecular Insights Into Stemness and Exhaustion.
    Gonzalez NM; Zou D; Gu A; Chen W
    Front Immunol; 2021; 12():725618. PubMed ID: 34512656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.
    Gill AL; Wang PH; Lee J; Hudson WH; Ando S; Araki K; Hu Y; Wieland A; Im S; Gavora A; Medina CB; Freeman GJ; Hashimoto M; Reiner SL; Ahmed R
    Sci Immunol; 2023 Aug; 8(86):eadg0539. PubMed ID: 37624909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-1/CTLA-4 Blockade Leads to Expansion of CD8
    Bufe S; Zimmermann A; Ravens S; Prinz I; Buitrago-Molina LE; Geffers R; Woller N; Kühnel F; Talbot SR; Noyan F; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E; Davalos-Misslitz AC
    Liver Cancer; 2023 Jun; 12(2):129-144. PubMed ID: 37325488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.
    Hu Y; Hudson WH; Kissick HT; Medina CB; Baptista AP; Ma C; Liao W; Germain RN; Turley SJ; Zhang N; Ahmed R
    J Exp Med; 2022 Oct; 219(10):. PubMed ID: 35980386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of B7RP-1 with ICOS negatively regulates antigen presentation by B cells.
    Wahl P; Schoop R; Horan TP; Yoshinaga SK; Wüthrich RP
    Inflammation; 2003 Aug; 27(4):191-200. PubMed ID: 14527172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting inducible costimulator expressed on CXCR5
    Kim AR; Han D; Choi JY; Seok J; Kim SE; Seo SH; Takahashi H; Amagai M; Park SH; Kim SC; Shin EC; Kim JH
    J Allergy Clin Immunol; 2020 Nov; 146(5):1070-1079.e8. PubMed ID: 32311391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
    Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
    Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-infiltrating mast cells stimulate ICOS
    Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
    J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR
    McClory SE; Bardhan O; Rome KS; Giles JR; Baxter AE; Xu L; Gimotty PA; Faryabi RB; Wherry EJ; Pear WS; Jordan MS
    Cell Rep; 2023 Aug; 42(8):112905. PubMed ID: 37527035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.
    Nanji SA; Hancock WW; Anderson CC; Adams AB; Luo B; Schur CD; Pawlick RL; Wang L; Coyle AJ; Larsen CP; Shapiro AM
    Am J Transplant; 2004 Apr; 4(4):526-36. PubMed ID: 15023144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.